Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study

Arushi Khurana; Raphael Mwangi; Rebecca L. King; Thomas M. Habermann; Stephen M. Ansell; James R. Cerhan; Grzegorz S. Nowakowski; Thomas E. Witzig; Matthew J. Maurer

doi:10.1182/blood-2022-169575

Back

Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study

Abstract

Open access

Peer reviewed

Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study

Arushi Khurana, Raphael Mwangi, Rebecca L. King, Thomas M. Habermann, Stephen M. Ansell, James R. Cerhan, Grzegorz S. Nowakowski, Thomas E. Witzig and Matthew J. Maurer

Blood, Vol.140(Supplement 1), pp.6666-6667

11/15/2022

DOI: 10.1182/blood-2022-169575

Files and links (1)

url

https://doi.org/10.1182/blood-2022-169575View

Published (Version of record) Open Access

Details

Title: Subtitle: Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study
Creators: Arushi Khurana - Mayo Clinic
Raphael Mwangi - Mayo Clinic
Rebecca L. King - Mayo Clinic
Thomas M. Habermann - Mayo Clinic
Stephen M. Ansell - Mayo Clinic
James R. Cerhan - Mayo Clinic
Grzegorz S. Nowakowski - Mayo Clinic
Thomas E. Witzig - Mayo Clinic
Matthew J. Maurer - Mayo Clinic
Resource Type: Abstract
Publication Details: Blood, Vol.140(Supplement 1), pp.6666-6667
DOI: 10.1182/blood-2022-169575
ISSN: 0006-4971
eISSN: 1528-0020
Language: English
Date published: 11/15/2022
Academic Unit: Epidemiology
Record Identifier: 9984368189502771

Metrics

17 Record Views